FDC Technical Momentum Shifts Amid Bearish Indicators in Pharmaceuticals Sector

The stock closed at ₹410.30, down 0.73% from the previous close of ₹413.30, trading within a daily range of ₹409.15 to ₹415.10. Over the past 52 weeks, FDC’s price has fluctuated between ₹358.95 and ₹530.00, indicating a wide volatility band. The technical trend adjustment is underscored by the Moving Average Convergence Divergence (MACD) indicator, which shows a bearish stance on the weekly chart and a mildly bearish position monthly. Meanwhile, the Relative Strength Index (RSI) remains neutral with no clear signal on both weekly and monthly timeframes.

Bollinger Bands analysis presents a mildly bearish outlook on the weekly scale and a bearish stance monthly, suggesting increased price volatility with downward pressure. Daily moving averages align with this bearish momentum, reinforcing the short-term negative trend. The Know Sure Thing (KST) indicator also reflects bearishness weekly and mildly bearish conditions monthly, further confirming the shift in momentum. Dow Theory analysis shows no definitive trend on the weekly chart but mildly bearish signals monthly, indicating a cautious market environment.

On the volume front, the On-Balance Volume (OBV) indicator shows no clear trend weekly but a bullish signal monthly, hinting at underlying accumulation despite price weakness. This divergence between volume and price momentum may suggest potential shifts in investor behaviour over the longer term.

FDC’s market capitalisation grade stands at 3, reflecting its mid-tier valuation within the Pharmaceuticals & Biotechnology sector. The Mojo Score currently reads 23.0, with a recent adjustment in evaluation noted on 3 November 2025, transitioning from a previous hold status to a strong sell indication as of 19 November 2025, triggered by technical parameter changes.

Examining FDC’s returns relative to the Sensex reveals mixed performance. Over the past week, FDC recorded a 0.35% return compared to Sensex’s 0.96%. The one-month period shows a negative return of 6.20% for FDC against a positive 0.86% for the Sensex. Year-to-date and one-year returns for FDC stand at -17.33% and -16.05% respectively, contrasting with Sensex gains of 8.36% and 9.48%. However, over longer horizons, FDC has outperformed the benchmark with a 43.69% return over three years versus Sensex’s 37.31%, and a 78.00% return over ten years compared to Sensex’s 232.28%, indicating variable performance across timeframes.

Investors analysing FDC should consider the current technical landscape marked by bearish momentum across multiple indicators, balanced by some bullish volume signals on a monthly basis. The divergence between price and volume metrics suggests a complex market dynamic that warrants close monitoring. The stock’s recent price action near the lower end of its 52-week range may attract attention from traders seeking potential inflection points, while the broader sector context and market conditions remain influential factors.

In summary, FDC’s technical parameter changes highlight a shift in momentum that aligns with cautious market sentiment in the Pharmaceuticals & Biotechnology sector. The interplay of bearish moving averages, MACD, and Bollinger Bands with neutral RSI and mixed volume trends presents a nuanced picture for investors. Continuous observation of these technical signals alongside fundamental developments will be essential for informed decision-making in the coming weeks.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →